tipiracil
FDA Approves LONSURF With Bevacizumab for Previously Treated mCRC
The FDA approved trifluridine and tipiracil (LONSURF, Taiho Oncology) with bevacizumab, for previously treated ...
AUGUST 26, 2024
FDA Approves LONSURF With Bevacizumab for Previously Treated Metastatic CRC
The FDA approved trifluridine and tipiracil (LONSURF) with bevacizumab, for metastatic colorectal cancer previously ...
AUGUST 10, 2023
Load more